MRNA - Moderna wins FDA approval for RSV vaccine
2024-05-31 11:11:00 ET
More on Moderna
- Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor
- Aggressive Strides Forward For Moderna's Cancer Vaccine
- Moderna Q1: A Promising Pipeline Is Undervalued
- Third human bird flu case found in U.S.
- Moderna nearing deal to win U.S. funding for bird flu vaccine trial: FT